Omicron Boosters Available From Next Month
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });
2022-11-26 HKT 09:22
Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.
The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.
"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."
Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.
The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.
The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.
mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.
OCBC Plans Hong Kong Wealth Expansion With Up To 50 New Bankers
OCBC is expending its wealth management team in Hong Kong by 30% this year to meet growing regional demand for investme... Read more
Hana Financial To Acquire US$669M Stake In Dunamu, Deepening Crypto Push
Hana Financial Group has agreed to acquire a 6.55% stake in digital asset operator Dunamu. The transaction is valued at... Read more
Reap And TerraPay Partner To Expand Cross-Border Payouts Via Local Payment Rails
Reap has partnered with TerraPay to expand its cross-border payout network using domestic clearing systems. The integra... Read more
Tencent Fintech And Cloud Services Lift Q1 2026 Revenue 9% To US$8.68 Billion
Tencent reported a 9% increase in revenue from its fintech and business services division for the first quarter of 2026... Read more
Ant Group Profit Falls An Estimated 79% As AI And Payments Spending Rises
Ant Group saw an estimated 79% decline in quarterly profit as the company accelerates its spending on AI, large languag... Read more
Alibabas Cloud Revenue Jumps 40% As AI Investments Pressure Profitability
Alibaba Group has released its financial results for the quarter and fiscal year ending 31 March 2026, reporting a 3% a... Read more